IntroductionErectile dysfunction (ED) is defined as the "inability to attain or maintain penile erection sufficient for satisfactory sexual performance".1 The prevalence of ED is increasing, and it is estimated that 322 million men worldwide will be affected by 2025, with the largest projected increase occurring in developing countries. 2 The prevalence of ED varies from 6.4-70.1%, and the wide variation is mainly due to the difference in assessment tools used, and the populations studied. [3][4][5][6][7][8] Physiologically, normal erection is maintained by a complex interplay between vascular and neurological events. Any condition that affects the vascular supply or the neuronal pathways to the penis, whether medical or psychological in origin, may cause ED. 1,9,10 Studies have shown that the prevalence of ED is significantly associated with age, the presence of co-morbid conditions and smoking. 3,4,6 Millions of men are affected by ED, often suffering in silence, while experiencing significant mental and psychological stress that affects their familial relationships and their social lives.
AbstractBackground: Erectile dysfunction (ED) is common amongst hypertensive men. Hypertensive patients often attribute it to antihypertensive drugs, although conflicting evidence linking ED with antihypertensive medication exists. The objectives were to determine the prevalence and severity of ED, the type of treatment sought, and the risk factors for ED among hypertensive men.